Buehlmann


Eiken Chemical Co., Ltd.


Eiken

EIKEN CHEMICAL CO., LTD., from its foundation in 1939, has been committed to contributing to public health and the prevention ofepidemics. In 1949, EIKEN CHEMICAL became the first Japanese company to successfully commercialize the manufacture of powdered culture media for microbiological investigations.

In addition to microbiological diagnosis, EIKEN CHEMICAL has played an active role in medical progress and public health through the development of clinical diagnostic aids vital to various aspects of contemporary medicine, including biochemical, immunological, serological, dry chemical diagnosis, in vivo diagnostics (contrast media), and automatic analyzers.

EIKEN CHEMICAL has established itself as a leader in the clinical diagnostics market, and maintains its commitment to public health through the development of products and technologies that fill needs at the cutting edge of contemporary medicine.

EIKEN products are very popular in R&D Projects and Clinical Studies. The main product is 2-5A SYNTHETASE RIA (see product list). The 2-5A Synthetase kit is very useful for the evaluation and monitoring of various types of infections (HIV), monitoring of efficacy when treated with IFN, or desease evolution such as SLE.

BÜHLMANN officially represents EIKEN CHEMICAL in Switzerland and in other key markets around the world.

Visit Eiken Homepage.

Contact

BÜHLMANN Laboratories AG
Baselstr. 55
CH-4124 Schönenbuch
Switzerland
Fon: +41 61 487 12 12
Fax: +41 61 487 12 34
info@buhlmannlabs.ch

Your local distributor
Order
About us
Job opportunities

News

NEW OWN CALPROTECTIN REIMBURSEMENT POSITION IN SWITZERLAND

BÜHLMANN is very proud to announce that the calprotectin determination in stool starting from January 1st 2012, has an official new position in the reimb  more

New Seegene DPO Movie showing how this unique and proprietary technology is working to allow innovative multiplexing.

The unique and proprietary DPO™(Dual-Priming-Oligonucleotide) technology is the corner stone for all of the Seegene products, and it is the key to achieve  more

New EntroGen BRAF test (V600E/K/D) for the detection of important mutations found in melanoma on your real-time PCR instrument.

EntroGen has a new BRAF test that detects, beside the V600E mutation, also the V600K and the V600D, which are important mutations found in melanoma.   more

BÜHLMANN innovations and news at the JIB

At the JIB Congress in Paris, 8th – 10th November 2011, BÜHLMANN presents the MDx products of EntroGen and AutoGenomics as well as new developments of its  more

Get our RSS - Feed